Morgan Stanley Lowers UiPath (NYSE:PATH) Price Target to $12.00

UiPath (NYSE:PATH – Free Report) had its target price trimmed by Morgan Stanley from $16.00 to $12.00 in a research report released on Thursday,Benzinga reports. The brokerage currently has an equal weight rating on the stock. A number of other research firms also recently commented on PATH. UBS Group began coverage on shares of UiPath […]

Leave a Reply

Your email address will not be published.

Previous post Proficio Capital Partners LLC Takes $9.28 Million Position in Tapestry, Inc. (NYSE:TPR)
Next post Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares Sold by M&T Bank Corp